Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Metabolome Analysis Reveals Dermal Histamine Accumulation in Murine Dermatitis Provoked by Genetic Deletion of P-Glycoprotein and Breast Cancer Resistance Protein.

Hashimoto N, Nakamichi N, Nanmo H, Kimura KI, Masuo Y, Sakai Y, Schinkel AH, Sato S, Soga T, Kato Y.

Pharm Res. 2019 Sep 11;36(11):158. doi: 10.1007/s11095-019-2695-3.

PMID:
31512001
2.

Maturational Characterization of Mouse Cortical Neurons Three-Dimensionally Cultured in Functional Polymer FP001-Containing Medium.

Nakamichi N, Matsumoto Y, Kawanishi T, Ishimoto T, Masuo Y, Horikawa M, Kato Y.

Biol Pharm Bull. 2019;42(9):1545-1553. doi: 10.1248/bpb.b19-00307.

3.

[Possible Treatment of Neuropsychiatric Disorders by Promotion of Neuronal Differentiation through Organic Cation Transporters].

Nakamichi N, Masuo Y, Kato Y.

Yakugaku Zasshi. 2019;139(6):847-852. doi: 10.1248/yakushi.18-00173-1. Review. Japanese.

4.

Bile Duct Obstruction Leads to Increased Intestinal Expression of Breast Cancer Resistance Protein With Reduced Gastrointestinal Absorption of Imatinib.

Kawanishi T, Arakawa H, Masuo Y, Nakamichi N, Kato Y.

J Pharm Sci. 2019 Sep;108(9):3130-3137. doi: 10.1016/j.xphs.2019.05.017. Epub 2019 May 25.

PMID:
31136764
5.

Hydrolyzed Salmon Milt Extract Enhances Object Recognition and Location Memory Through an Increase in Hippocampal Cytidine Nucleoside Levels in Normal Mice.

Nakamichi N, Nakao S, Masuo Y, Koike A, Matsumura N, Nishiyama M, Al-Shammari AH, Sekiguchi H, Sutoh K, Usumi K, Kato Y.

J Med Food. 2019 Apr;22(4):408-415. doi: 10.1089/jmf.2018.4285.

PMID:
30990754
6.

Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.

Iwase M, Fujita KI, Nishimura Y, Seba N, Masuo Y, Ishida H, Kato Y, Kiuchi Y.

Cancer Chemother Pharmacol. 2019 May;83(5):993-998. doi: 10.1007/s00280-019-03784-8. Epub 2019 Feb 13.

PMID:
30810774
7.

Influx and Efflux Transporters Contribute to the Increased Dermal Exposure to Active Metabolite of Regorafenib After Repeated Oral Administration in Mice.

Al-Shammari AH, Masuo Y, Fujita KI, Yoshikawa Y, Nakamichi N, Kubota Y, Sasaki Y, Kato Y.

J Pharm Sci. 2019 Jun;108(6):2173-2179. doi: 10.1016/j.xphs.2019.01.018. Epub 2019 Jan 24.

PMID:
30685396
8.

Ergothioneine-induced neuronal differentiation is mediated through activation of S6K1 and neurotrophin 4/5-TrkB signaling in murine neural stem cells.

Ishimoto T, Masuo Y, Kato Y, Nakamichi N.

Cell Signal. 2019 Jan;53:269-280. doi: 10.1016/j.cellsig.2018.10.012. Epub 2018 Oct 22.

PMID:
30359715
9.

Combination Metabolomics Approach for Identifying Endogenous Substrates of Carnitine/Organic Cation Transporter OCTN1.

Masuo Y, Ohba Y, Yamada K, Al-Shammari AH, Seba N, Nakamichi N, Ogihara T, Kunishima M, Kato Y.

Pharm Res. 2018 Oct 2;35(11):224. doi: 10.1007/s11095-018-2507-1.

PMID:
30280275
10.

Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib.

Ellawatty WEA, Masuo Y, Fujita KI, Yamazaki E, Ishida H, Arakawa H, Nakamichi N, Abdelwahed R, Sasaki Y, Kato Y.

Drug Metab Dispos. 2018 Jan;46(1):33-40. doi: 10.1124/dmd.117.076554. Epub 2017 Oct 31.

PMID:
29089306
11.

Carnitine/Organic Cation Transporter OCTN1 Negatively Regulates Activation in Murine Cultured Microglial Cells.

Ishimoto T, Nakamichi N, Nishijima H, Masuo Y, Kato Y.

Neurochem Res. 2018 Jan;43(1):116-128. doi: 10.1007/s11064-017-2350-5. Epub 2017 Jul 8.

PMID:
28688036
12.

Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway.

Takahashi S, Tanaka N, Golla S, Fukami T, Krausz KW, Polunas MA, Weig BC, Masuo Y, Xie C, Jiang C, Gonzalez FJ.

Toxicol Sci. 2017 Aug 1;158(2):334-346. doi: 10.1093/toxsci/kfx094.

13.

Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active Metabolites.

Fujita KI, Masuo Y, Yamazaki E, Shibutani T, Kubota Y, Nakamichi N, Sasaki Y, Kato Y.

J Pharm Sci. 2017 Sep;106(9):2632-2641. doi: 10.1016/j.xphs.2017.04.064. Epub 2017 May 4.

PMID:
28479358
14.

VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body.

Yamamoto H, Takada T, Yamanashi Y, Ogura M, Masuo Y, Harada-Shiba M, Suzuki H.

Sci Rep. 2017 Apr 4;7(1):633. doi: 10.1038/s41598-017-00685-9.

15.

Utilization of Liver Microsomes to Estimate Hepatic Intrinsic Clearance of Monoamine Oxidase Substrate Drugs in Humans.

Masuo Y, Nagamori S, Hasegawa A, Hayashi K, Isozumi N, Nakamichi N, Kanai Y, Kato Y.

Pharm Res. 2017 Jun;34(6):1233-1243. doi: 10.1007/s11095-017-2140-4. Epub 2017 Mar 30.

PMID:
28361200
16.

P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids.

Hashimoto N, Nakamichi N, Yamazaki E, Oikawa M, Masuo Y, Schinkel AH, Kato Y.

Int J Pharm. 2017 Apr 15;521(1-2):365-373. doi: 10.1016/j.ijpharm.2017.02.064. Epub 2017 Feb 24.

PMID:
28242377
17.

[Axillary Lymph Node Dissection and Chemotherapy were Useful for Occult Cancer - Report of a Case].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Hirano T, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2065-2067. Japanese.

PMID:
28133223
18.

[Difficult Decision about a Surgical Margin for a Non-Invasive Apocrine Carcinoma in the Breast - Report of a Case].

Hirano T, Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2013-2015. Japanese.

PMID:
28133206
19.

[Intra-Cystic Mucinous Carcinoma of the Breast - A Case Report].

Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Hirano T, Enomoto K, Sakurai K, Makishima M, Koshinaga T.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1547-1549. Japanese.

PMID:
28133052
20.

[Breast Cancer with Microinvasion and Lymph Node Metastasis Diagnosed by Microdochectomy - Report of a Case].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Hirano T, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1455-1457. Japanese.

PMID:
28133021
21.

Validity of segmental bioelectrical impedance analysis for estimating fat-free mass in children including overweight individuals.

Ohta M, Midorikawa T, Hikihara Y, Masuo Y, Sakamoto S, Torii S, Kawakami Y, Fukunaga T, Kanehisa H.

Appl Physiol Nutr Metab. 2017 Feb;42(2):157-165. doi: 10.1139/apnm-2016-0137. Epub 2016 Oct 14.

PMID:
28112969
22.

Preventive Effect of Salicylate and Pyridoxamine on Diabetic Nephropathy.

Abouzed TK, Munesue S, Harashima A, Masuo Y, Kato Y, Khailo K, Yamamoto H, Yamamoto Y.

J Diabetes Res. 2016;2016:1786789. doi: 10.1155/2016/1786789. Epub 2016 Nov 30.

23.

Neonatal rotenone lesions cause onset of hyperactivity during juvenile and adulthood in the rat.

Ishido M, Suzuki J, Masuo Y.

Toxicol Lett. 2017 Jan 15;266:42-48. doi: 10.1016/j.toxlet.2016.12.008. Epub 2016 Dec 12.

PMID:
27979718
24.

[Indoleamine 2,3-Dioxygenase Activity in Intracystic Breast Tumors].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Enomoto K, Hirano T, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1295-1297. Japanese.

PMID:
27760965
25.

[Clinical Evaluation of Immunosuppressive Acidic Protein in the Serum of Patients with Locally Advanced Breast Cancer during Mohs Paste Treatment].

Hirano T, Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1283-1285. Japanese.

PMID:
27760961
26.

[Study of the Immunological Stress Caused by Breast Surgery Methods].

Hirano T, Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1274-1276. Japanese.

PMID:
27760958
27.

[Study of the Relationship between Obesity and Lymphocytes in Breast Cancer Patients Undergoing Chemotherapy].

Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Hirano T, Enomoto K, Sakurai K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1246-1248. Japanese.

PMID:
27760949
28.

[Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Multiple Metastatic Breast Cancer Patients].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Hirano T, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1233-1236. Japanese.

PMID:
27760945
29.

Screening to Identify Multidrug Resistance-Associated Protein Inhibitors with Neuroblastoma-Selective Cytotoxicity.

Nakamichi N, Ishimoto T, Yamauchi Y, Masuo Y, Kato Y.

Biol Pharm Bull. 2016;39(10):1638-1645.

30.

Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.

Takahashi S, Fukami T, Masuo Y, Brocker CN, Xie C, Krausz KW, Wolf CR, Henderson CJ, Gonzalez FJ.

J Lipid Res. 2016 Dec;57(12):2130-2137. Epub 2016 Sep 16.

31.

L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides.

Futatsugi A, Masuo Y, Kawabata S, Nakamichi N, Kato Y.

J Pharm Pharmacol. 2016 Sep;68(9):1160-9. doi: 10.1111/jphp.12574. Epub 2016 Jun 28.

PMID:
27350110
32.

Unraveling the rat blood genome-wide transcriptome after oral administration of lavender oil by a two-color dye-swap DNA microarray approach.

Hori M, Kubo H, Shibato J, Saito T, Ogawa T, Wakamori M, Masuo Y, Shioda S, Rakwal R.

Genom Data. 2016 May 12;8:139-45. doi: 10.1016/j.gdata.2016.05.005. eCollection 2016 Jun.

33.

Characterization of Long-Lasting Oatp Inhibition by Typical Inhibitor Cyclosporine A and In Vitro-In Vivo Discrepancy in Its Drug Interaction Potential in Rats.

Taguchi T, Masuo Y, Kogi T, Nakamichi N, Kato Y.

J Pharm Sci. 2016 Jul;105(7):2231-9. doi: 10.1016/j.xphs.2016.04.025. Epub 2016 Jun 9.

PMID:
27290622
34.

Food-derived hydrophilic antioxidant ergothioneine is distributed to the brain and exerts antidepressant effect in mice.

Nakamichi N, Nakayama K, Ishimoto T, Masuo Y, Wakayama T, Sekiguchi H, Sutoh K, Usumi K, Iseki S, Kato Y.

Brain Behav. 2016 Apr 22;6(6):e00477. doi: 10.1002/brb3.477. eCollection 2016 Jun.

35.

Localization of Xenobiotic Transporter OCTN1/SLC22A4 in Hepatic Stellate Cells and Its Protective Role in Liver Fibrosis.

Tang Y, Masuo Y, Sakai Y, Wakayama T, Sugiura T, Harada R, Futatsugi A, Komura T, Nakamichi N, Sekiguchi H, Sutoh K, Usumi K, Iseki S, Kaneko S, Kato Y.

J Pharm Sci. 2016 May;105(5):1779-1789. doi: 10.1016/j.xphs.2016.02.023. Epub 2016 Mar 25.

PMID:
27020986
36.

[Study of the Identification Rate of Sentinel Lymph Node Biopsy after Partial Breast Resection].

Suzuki S, Sakurai K, Adachi K, Masuo Y, Nagashima S, Hara Y, Amano S, Enomoto K, Makishima M.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1791-3. Japanese.

PMID:
26805174
37.

[Interval Breast Cancer with Neuroendocrine Differentiation].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Tomita R, Gonda K, Hirano T, Enomoto K, Amano S.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1770-2. Japanese.

PMID:
26805167
38.

[Usefulness of Local Therapy in Elderly Breast Cancer Patients with Distant Metastases].

Sakurai K, Fujisaki S, Suzuki S, Adachi K, Masuo Y, Nagashima S, Hara Y, Enomoto K, Tomita R, Gonda K, Hirano T, Amano S.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1503-5. Japanese.

PMID:
26805077
39.

DNA microarray unravels rapid changes in transcriptome of MK-801 treated rat brain.

Kobayashi Y, Kulikova SP, Shibato J, Rakwal R, Satoh H, Pinault D, Masuo Y.

World J Biol Chem. 2015 Nov 26;6(4):389-408. doi: 10.4331/wjbc.v6.i4.389.

40.

[Indoleamine 2,3-Dioxygenase Activity during I131-Radioisotope Therapy for Metastatic Thyroid Cancer].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Tomita R, Gonda K, Hirano T, Enomoto K.

Gan To Kagaku Ryoho. 2015 Oct;42(10):1259-61. Japanese.

PMID:
26489565
41.

[Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Aromatase Inhibitor-Resistant Metastatic Breast Cancer].

Sakurai K, Fujisaki S, Suzuki S, Adachi K, Nagashima S, Masuo Y, Tomita R, Gonda K, Enomoto K, Amano S, Matsuo S, Umeda N.

Gan To Kagaku Ryoho. 2015 Oct;42(10):1225-7. Japanese.

PMID:
26489554
42.

Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure.

Fujita K, Masuo Y, Okumura H, Watanabe Y, Suzuki H, Sunakawa Y, Shimada K, Kawara K, Akiyama Y, Kitamura M, Kunishima M, Sasaki Y, Kato Y.

Pharm Res. 2016 Feb;33(2):269-82. doi: 10.1007/s11095-015-1785-0. Epub 2015 Sep 3.

PMID:
26337772
43.

Organic cation transporter Octn1-mediated uptake of food-derived antioxidant ergothioneine into infiltrating macrophages during intestinal inflammation in mice.

Shimizu T, Masuo Y, Takahashi S, Nakamichi N, Kato Y.

Drug Metab Pharmacokinet. 2015 Jun;30(3):231-9. doi: 10.1016/j.dmpk.2015.02.003. Epub 2015 Feb 25.

PMID:
26003890
44.

Gene ablation of carnitine/organic cation transporter 1 reduces gastrointestinal absorption of 5-aminosalicylate in mice.

Shimizu T, Kijima A, Masuo Y, Ishimoto T, Sugiura T, Takahashi S, Nakamichi N, Kato Y.

Biol Pharm Bull. 2015;38(5):774-80. doi: 10.1248/bpb.b15-00109.

45.

NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy.

Takada T, Yamanashi Y, Konishi K, Yamamoto T, Toyoda Y, Masuo Y, Yamamoto H, Suzuki H.

Sci Transl Med. 2015 Feb 18;7(275):275ra23. doi: 10.1126/scitranslmed.3010329.

PMID:
25696002
46.

Lactobacillus salivarius WB21-containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial--reply to letter.

Suzuki N, Yoneda M, Tanabe K, Fujimoto A, Iha K, Seno K, Yamada K, Iwamoto T, Masuo Y, Hirofuji T.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Oct;118(4):506. doi: 10.1016/j.oooo.2014.06.014. Epub 2014 Jul 18. No abstract available.

PMID:
25241000
47.

Expression of BDNF and TH mRNA in the brain following inhaled administration of α-pinene.

Kasuya H, Okada N, Kubohara M, Satou T, Masuo Y, Koike K.

Phytother Res. 2015 Jan;29(1):43-7. doi: 10.1002/ptr.5224. Epub 2014 Sep 17.

PMID:
25230317
48.

Organic cation transporter-mediated ergothioneine uptake in mouse neural progenitor cells suppresses proliferation and promotes differentiation into neurons.

Ishimoto T, Nakamichi N, Hosotani H, Masuo Y, Sugiura T, Kato Y.

PLoS One. 2014 Feb 25;9(2):e89434. doi: 10.1371/journal.pone.0089434. eCollection 2014.

49.

Lactobacillus salivarius WB21--containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial.

Suzuki N, Yoneda M, Tanabe K, Fujimoto A, Iha K, Seno K, Yamada K, Iwamoto T, Masuo Y, Hirofuji T.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Apr;117(4):462-70. doi: 10.1016/j.oooo.2013.12.400. Epub 2013 Dec 20.

PMID:
24556493
50.

Effects of S-PRG eluate on oral biofilm and oral malodor.

Suzuki N, Yoneda M, Haruna K, Masuo Y, Nishihara T, Nakanishi K, Yamada K, Fujimoto A, Hirofuji T.

Arch Oral Biol. 2014 Apr;59(4):407-13. doi: 10.1016/j.archoralbio.2014.01.009. Epub 2014 Feb 1.

PMID:
24530472

Supplemental Content

Support Center